AF
WVE icon

Amalgamated Financial’s Wave Life Sciences WVE Stock Holding History

Amalgamated Financial’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$14K Buy
+7,218
New +$17.7K ﹤0.01% 2840

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Amalgamated Financial's WVE Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Wave Life Sciences (WVE) in Q1 2022: 7,218 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #2840 among its holdings.

82 funds tracked by Wall St. Rank hold WVE as of Q1 2022.

  • Amalgamated Financial held 7,218 shares of Wave Life Sciences worth $14K as of Q1 2022.
  • Wave Life Sciences was a new Amalgamated Financial position in Q1 2022.
  • Wave Life Sciences made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2840 holding.
  • 82 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.